PBTC-042 - Phase I study of CDK 4-6 inhibitor PD-0332991 in children with recurrent, progressive or refractory central nervous system tumors

Project: Research project

Project Details

StatusActive
Effective start/end date9/5/1412/31/20

Funding

  • St. Jude Children's Research Hospital
  • Pfizer Inc.